Hemangioma Clinical Trial
Official title:
Hemangioma Associated With High Rates of Morbidity:A Prospective Study
We are conducting a study on the possible presence of PHACES in children with large facial hemangiomas and lumbosacral hemangiomas of infancy (hemangioma in the lower back) . With this study we hope to better understand the risk of this syndrome and to develop guidelines for its evaluation and management.
Large hemangiomas of the face can be associated with anomalies of the blood vessels of head
and chest. The acronym PHACES indicates the association of Posterior fossa and other brain
malformations, facial Hemangioma, Arterial anomalies, Coarctation of the aorta and other
cardiac defects, Eye abnormalities and Sternal malformations. Study subjects will be
recruited through the Pediatric Dermatology department in several cities. All patients age
0-1 year old of age, who present with large facial hemangioma (>22 cm^2) will be offered to
participate in the study. Parents will be interviewed to obtain personal, medical, and
family history.
Patients will undergo standard of care evaluation for facial hemangioma with risk of PHACE
syndrome. This includes skin, eye and neurological examination, photograph, magnetic
resonance imaging (MRI) of head/neck/chest, and lab tests requiring samples of blood, urine
or stool. No other tests will be performed for participating in the study.
Lumbosacral hemangiomas of infancy (hemangioma in the lower back) can be associated with
anomalies of the spine. "Tethered cord syndrome" indicates a condition caused by abnormally
stretched spinal cord. Over time this condition can lead to neurological damage. Although
often there are no symptoms until adulthood, it can become apparent during childhood. Common
symptoms are: lower back pain, pain and weakness of the legs, walking problems, and bladder
and bowel loss of control. "Occult spinal dysraphism" is the term used when the defect of
the spine is hidden under normal skin. We noticed that infants with hemangioma in the lower
back area are more inclined to present a hidden spine defect.
Study subjects will be recruited through the Pediatric Dermatology departments in several
cities. All patients age 0-18 year old of age, who present with lumbosacral hemangioma (>
2.5 cm of diameter overlying the spine) will be offered to participate in the study. Parents
will be interviewed to obtain personal, medical, and family history.
Patients will undergo standard of care evaluation for lumbosacral hemangioma. This includes
skin, neurological examination, photograph, magnetic resonance imaging (MRI) of the back,
lab tests requiring samples of blood, urine or stool. No additional tests will be performed
only for participating in the study.
;
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01685398 -
Topical Timolol for Superficial Infantile Hemangioma
|
Phase 3 | |
Withdrawn |
NCT00974129 -
A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas
|
N/A | |
Completed |
NCT00374335 -
Incidence of Hepatic Hemangiomatosis in Patients With Cutaneous Hemangiomas
|
N/A | |
Recruiting |
NCT03331744 -
Clinical Characteristics of Infantile Hemangioma
|
||
Completed |
NCT02342275 -
Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma
|
Phase 3 | |
Completed |
NCT00433940 -
Immune Suppression Of Infants Treated With Steroids
|
N/A | |
Completed |
NCT04065217 -
The Effectiveness of Diode Laser 980-nm in Iraqi Face Hemangioma: a Randomized Within Patients Trial
|
N/A | |
Terminated |
NCT01743885 -
Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma
|
Phase 3 | |
Terminated |
NCT00555464 -
Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas
|
Phase 2 | |
Completed |
NCT05327309 -
Role of Propranolol as Compared to Bleomycin in Management of Hemangioma
|
N/A | |
Completed |
NCT02145884 -
Topical Timolol Gel for the Treatment of Infantile Hemangiomas
|
Phase 2 | |
Completed |
NCT04077515 -
Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma
|
Phase 4 | |
Completed |
NCT02731287 -
Topical Timolol for Infantile Hemangioma in Early Proliferative Phase
|
Phase 2 | |
Recruiting |
NCT01147601 -
Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas
|
Phase 0 | |
Completed |
NCT01908972 -
The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma
|
Phase 4 | |
Completed |
NCT00540566 -
Optical Biopsy of Human Skin in Conjunction With Laser Treatment
|
||
Completed |
NCT00001417 -
Direct Injection of Alcohol for the Treatment of Spinal Tumors
|
N/A | |
Completed |
NCT00004436 -
Randomized Study of Hormonal Regulation of Infantile Hemangioma
|
N/A | |
Recruiting |
NCT02496013 -
Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB
|
Phase 1 | |
Completed |
NCT01072045 -
Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma
|
Phase 2 |